Should I buy Ryan Specialty (RYAN) stock or is it too late?

Ryan Specialty · Financials · price $38

See the full Ryan Specialty (RYAN) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Mizuho — 79% of its targets hit on this sector (29 calls tested). It aims for $40 (+5.7 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).

The 8 reliable analysts $49.25+30 %

The 4 other firms $46.50+23 %

How to read it: the 8 reliable firms are not filtered by optimism — 8 aim above the price, 0 below, hence their $49.25 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Ryan Specialty

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	75 %	+11.8 %	8	$41 +8%
Keefe, Bruyette & Woods	50 %	-3.3 %	6	$54 +43%
Barclays	38 %	-6.1 %	8	$48 +27%
UBS	33 %	-6.5 %	6	$55 +45%
JP Morgan	33 %	-9.6 %	6	$45 +19%
Morgan Stanley	0 %	-36.9 %	7	$50 +32%

In short — Should you invest in Ryan Specialty? Is it too late, still worth it? Analysts are split (50% buy, median target $47, i.e. +23%), and the most reliable on RYAN targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $47, i.e. +23% from the current price ($38).
The most reliable firm on RYAN, RBC Capital (100% hit rate, 2 scored calls), targets $55 (call made on July 31, 2026, maturing on July 31, 2027) (+45%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 12 ratings, 5 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on RYAN

Median target $47 (+23%) · 12 ratings · Hold consensus

Strong Buy00%

Buy650%

Hold542%

Sell18%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Ryan Specialty now?

We won't decide for you. The facts: 50% of analysts rate it a buy, median target $47 (+23%), and RBC Capital (most reliable on RYAN, 100%) targets $55. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Ryan Specialty?

Not according to analysts: the median target ($47) is still +23% above the current price ($38) (most reliable on RYAN: RBC Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Ryan Specialty still worth investing in?

It depends on the gap between the price ($38) and its estimated value: analysts target $47 on median (+23%), with 50% buys (most reliable on RYAN: RBC Capital, 100%). Cross-check with their real reliability on RYAN and the cautions above. Information, not advice.

What's the main risk in buying RYAN?

The consensus is not unanimous: of 12 ratings, 5 are neutral and 1 is a sell.

→ Go deeper: the full Ryan Specialty profile (consensus, analyst reliability, price target, performance).